Commercial
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Companies
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

Boston Scientific Puts Charge In Neuromodulation Business By Acquiring Relievant
Relievant’s Intracept intraosseous nerve ablation system is the only FDA-cleared neuromodulation device indicated to treat vertebrogenic pain. Boston Scientific will pay $850m for Relievant, plus undisclosed milestone payments over the next three years.

Medtech DEI Experts Talk Shop: ‘It’s Going To Transform Businesses’
An all-female panel of medtech DEI leaders at the LSX Congress USA conference discussed the importance of diversity and inclusion in research, clinical trials, product development and services to advance health equity as well as fundamental business goals.

Federal Court Rejects Motion To Dismiss Case In Genomics Patent Infringement Suit
Parse Biosciences’ motion to dismiss a patent infringement case has been rejected by a US District Court.

FDA Updates Breakthrough Devices Guidance To Improve Health Equity
The US FDA has updated its final guidance to clarify use of the Breakthrough Devices Program in advancing health equity. The voluntary program was created to speed up the process of getting innovative medical devices to patients that treat life-threatening or debilitating diseases.
Deals and Financings
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

Boston Scientific Puts Charge In Neuromodulation Business By Acquiring Relievant
Relievant’s Intracept intraosseous nerve ablation system is the only FDA-cleared neuromodulation device indicated to treat vertebrogenic pain. Boston Scientific will pay $850m for Relievant, plus undisclosed milestone payments over the next three years.

Minute Insight: 15,000 Surgeries And More Funding For CMR Surgical
The UK-based company has just raised $165m support the ongoing commercialization of the Versius robotic platform.

Abbott Buys Bigfoot Biomedical – But What Lurks In The Forest?
Abbott and Bigfoot Biomedical have worked as partners for more than half a decade but will now continue as one. Analysts are questioning whether the merger will simply be a tuck-in for Abbott, or enable it to release an insulin pump of their own.

Digital Health Roundup: VR, AI Trends In Rehabilitation; Cybersecurity Regulations; Medicare Updates
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights VR, AI and other high tech trends in rehabilitation and gait training. Hannah Daniel discusses cybersecurity updates such as the new NIST published draft for an updated version of the Cybersecurity Framework, a recent report by Health-ISAC, and an interview with MedCrypt’s Naomi Schwartz about the upcoming FDA cybersecurity regulations for premarket approvals.
Market Access
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

China: Value-Based Procurement Reshapes Strategies Of Multinational Medtech Firms
China’s growing market for medtech, estimated at $70bn in 2021, could more than double this decade if the government’s Healthy China 2030 plan stays on track.

Pan-EU Health Data Sharing Platform Takes Shape
Technical teams have laid the cornerstone for the platform that will be developed to link up multiple public and private data sources and make it easier to access, integrate and analyze the vast and diverse range of data they contain.

Patent Office To Drop Some Proposed Revisions To Patent Challenge Proceedings, Vidal Tells Congress
Not all PTAB changes floated in advanced notice of proposed rulemaking will be pursued, and the rule may be split into two, USPTO Director Vidal testifies. Industry groups criticize the proposals.

German Hospital Payment Reform ‘Revolution’ On Track For January 2024
The major reform of Germany’s DRG payment system moved to the next stage after a federal-state working group delivered a key points document on 10 July. January 2024 remains the effective date for the system overhaul, which the government says meets health care budgetary and quality needs.
Market Intelligence
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

‘Faster, Better, More Efficient’ – Why Bayer Is Investing In ‘Precision Health’
Bayer's head of R&D and chief scientific officer David Evendon-Challis talked to Medtech Insight about the company's prescision health business, including a holistic and personalized approach to digital self-care.

Pear Bankruptcy Filing Highlights Difficult Challenges Facing Digital Therapeutics
Pear Therapeutics filed for Chapter 11 bankruptcy in April and sold its remaining assets in an auction for about $6m. The demise of one the pioneers in the prescription digital therapeutics industry highlights the challenges PDT developers face getting their products reimbursed.

Haleon's Nick Tate: Tech Partnerships Key To Unlocking Digital Consumer Health Future
“There’s no one company, government, person or technology who is positioned to ‘solve’ the health of the world,” notes Haleon's Nick Tate. Which is why OTC companies are partnering with tech firms large and small to create the next generation of consumer healthcare products and services. In the first part of an exclusive interview on the future of digital consumer health, Tate – who heads up the firm’s incubator business, Haleon NEXT – discusses some of the complications of tech innovation that make such collaboration attractive.

MDIC Cybersecurity Benchmarking Maturity Report: An ‘Honest Reflection’ Of The Industry
In an event hosted by the Medical Device Innovation Consortium, cybersecurity experts discussed a benchmark report on the state of cybersecurity in the device industry. The director of digital health product security policy at Medtronic previewed the updated Joint Security Plan.
Appointments
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

Minute Insight: Illumina Seeks Stability, Names Thaysen As New CEO
The genome-sequencing giant has named Jacob Thaysen, who brings extensive experience from Agilent, as its new leader.

Tornos Ascends To Zimmer Biomet CEO As Hanson Leaves For 3M Spinoff
Ivan Tornos will shift from COO to CEO of Zimmer Biomet now that former CEO Bryan Hanson has accepted the CEO job at 3M’s health care spinoff.

Execs On The Move, July 2023: Electromed, NeuroPace, Name New CEOs
An interactive summary of recent executive-level company changes and promotions in the medical device and diagnostics sectors.

Downturn In Demand For EU Medtech Regulatory Talent Starting To Turn Around
Against a globally tough environment, recruitment for EU medtech regulatory roles slowed down. Elemed’s Elena Kyria explains what is shaping talent hiring now there are signs of an uptick and how job seekers and recruiters can best position themselves
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.